Related Experiment Video
Updated: May 20, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Mitral valve surgical procedures in the elderly
Joerg Seeburger1, Volkmar Falk, Jens Garbade
1Department of Cardiac Surgery, University Heart Center Leipzig, Germany. seej@med.uni-leipzig.de
Background:
Mitral valve (MV) surgical procedures in the elderly are associated with profound operative and long-term mortality. We report our experience and results for MV surgical procedures in the elderly, especially with regard to the influence of comorbidities.
Methods:
Our hospital database was assessed to identify all patients who underwent MV surgical procedures at the age of 70 years and older between 1999 and 2009. The data were retrospectively analyzed.
Results:
A total of 2,503 patients operated on during this 10-year period were identified. In 97% of patients, mitral regurgitation (MR) was the primary indication for operation, followed by coronary artery disease in 41.6% and aortic valve stenosis in 21.3%. The 30-day mortality rate was 3.1%, and the long-term survival at 5 years was 55.2% (95% confidence interval, 52.3% to 57.5%). Coronary artery bypass grafting was identified to be associated with inferior short-term and long-term survival. Numerous comorbidities significantly influenced long-term survival. The observed mortality was significantly lower than predicted by EuroSCORE (17.2%).
Conclusions:
MV operations in the elderly can be performed with a low early mortality and promising long-term survival. However, our large series demonstrates that comorbidities are to be attributed as the real burden for successful treatment of elderly patients undergoing MV procedures.
Insights
Mitral valve (MV) surgery in elderly patients shows low early mortality and good long-term survival. However, comorbidities significantly impact outcomes, posing the main challenge for successful treatment.
Area of Science:
- Cardiovascular Surgery
- Geriatric Medicine
- Clinical Outcomes Research
Background:
- Elderly patients undergoing mitral valve (MV) surgery face high operative and long-term mortality risks.
- Comorbidities significantly influence outcomes in this patient population.
Purpose of the Study:
- To report surgical outcomes for elderly patients (≥70 years) undergoing MV procedures.
- To investigate the impact of comorbidities on mortality and survival in this cohort.
Main Methods:
- Retrospective analysis of a hospital database.
- Inclusion of 2,503 patients aged 70 years and older who underwent MV surgery between 1999 and 2009.
Main Results:
- Mitral regurgitation was the primary indication for 97% of operations.
- 30-day mortality was 3.1%, with 5-year survival at 55.2%.
- Comorbidities significantly affected long-term survival; coronary artery bypass grafting was linked to poorer outcomes.
Conclusions:
- Mitral valve operations in the elderly can achieve low early mortality and favorable long-term survival.
- Comorbidities represent a significant challenge impacting the success of MV procedures in older adults.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse III: Nursing Management
Mitral Stenosis IV: Nursing Management
Mitral Regurgitation IV: Nursing Management

